| 000 | 01264cam a2200361 a 4500 | ||
|---|---|---|---|
| 001 | 16797708 | ||
| 003 | OSt | ||
| 005 | 20160608111652.0 | ||
| 008 | 110523s2013 maua b 001 0 eng | ||
| 010 | _a 2011022068 | ||
| 020 | _a9780763770990 (pbk. : alk. paper) | ||
| 035 | _a(DNLM)101561221 | ||
| 040 |
_aDNLM/DLC _cDLC _dDLC |
||
| 042 | _apcc | ||
| 050 | 0 | 0 |
_aRS100 _b.U53 2013 |
| 060 | 1 | 0 | _aQV 736 |
| 082 | 0 | 0 |
_a338.4/76151 _223 |
| 245 | 0 | 0 |
_aUnderstanding health outcomes and pharmacoeconomics / _c[edited by] George E. MacKinnon III. |
| 260 |
_aBurlington, MA : _bJones & Bartlett Learning, _cc2013. |
||
| 300 |
_axxii, 218 p. : _bill. ; _c23 cm. |
||
| 504 | _aIncludes bibliographical references and index. | ||
| 650 | 0 |
_aPharmaceutical industry _xEconomic aspects. |
|
| 650 | 0 |
_aDrugs _xCost effectiveness. |
|
| 650 | 0 |
_aDrug development _xEconomic aspects. |
|
| 650 | 0 | _aOutcome Assessment (Health Care) | |
| 650 | 1 | 2 | _aEconomics, Pharmaceutical. |
| 650 | 2 | 2 |
_aCosts and Cost Analysis _xmethods. |
| 650 | 2 | 2 |
_aOutcome Assessment (Health Care) _xeconomics. |
| 700 | 1 | _aMacKinnon, George E. | |
| 906 |
_a7 _bcbc _corignew _d1 _eecip _f20 _gy-gencatlg |
||
| 942 |
_2ddc _cBK |
||
| 999 |
_c3567 _d3567 |
||